3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
Paclitaxel
24
Oxaliplatin
24
Capecitabine
24
Gemcitabine
21
Cisplatin
21
Fluorouracil
20
Drug Therapy
18
Docetaxel
18
Carboplatin
17
pembrolizumab
15
Leucovorin
15
Irinotecan
15
Radiotherapy
12
tislelizumab
11
Magnetic Resonance Spectroscopy
10
Bevacizumab
10
Specimen Handling
9
Pemetrexed
9
Radiation
8
Injections
8
Cetuximab
8
toripalimab
7
Surgical Procedures, Operative
7
Radiotherapy, Intensity-Modulated
7
Azacitidine
7
venetoclax
6
sintilimab
6
Trastuzumab
6
Topotecan
6
Standard of Care
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Not yet recruiting
×
CVAD protocol
×
Clear all
NCT07223190
2026-03-04
AUDAX
Amgen
Phase 3
Not yet recruiting
560 enrolled